Menu Search
Equities

Menicon Co Ltd

5FR:DUS

Menicon Co Ltd

Actions
  • Price (EUR)9.60
  • Today's Change-0.300 / -3.03%
  • Shares traded100.00
  • 1 Year change-18.64%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024 15:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Menicon Co., Ltd. is a Japan-based company mainly engaged in operation of contact lens related business and other business. The Company has two business segments. With its subsidiaries, the Contact Lens segment is engaged in manufacture and sales of contact lens, care supplies and other goods. The Others segment is engaged in development and sales of veterinary medical products, decomposition accelerator of rice straw, composting accelerator of livestock excrement, assisted reproductive medicine and products of advanced medical fields, as well as management of contact lens retailer staff training school and provision of temporary staffing service, among others.

  • Revenue in JPY (TTM)118.64bn
  • Net income in JPY4.84bn
  • Incorporated1957
  • Employees4.22k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		7780:TYO since
announced		Transaction
value
PT Oculus IndonesiaDeal completed30 Sep 202430 Sep 2024Deal completed9.06%--
Oculus visioncare (S) Pte LtdDeal completed30 Sep 202430 Sep 2024Deal completed9.06%--
Oculus (M) Sdn BhdDeal completed30 Sep 202430 Sep 2024Deal completed9.06%--
Dencott Laboratories SADeal completed04 Apr 202404 Apr 2024Deal completed6.20%--
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.